Vibativ Injection, Powder, Lyophilized, For Solution
Product Images NDC 66220-315

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Vibativ (NDC 66220-315). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cumberland Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Vib09 0001 01)

FDA Label Image

Principal Display Panel (750 mg/vial Carton Label)

VIBATIV® (telavancin) for injection is a sterile, lyophilized, preservative-free medication used for intravenous infusion only. It is reconstituted using 5% Dextrose Injection, USP, Sterile Water for Injection, USP or 0.9% Sodium Chloride Injection, USP. Each vial contains telavancin hydrochloride of 750mg. The medication is manufactured by Cumberland Pharmaceuticals Inc., Nashville, TN. Further instructions for use can be located in the package insert.*

FDA Label Image

Principal Display Panel (750 mg/vial Vial Label)

NDC 66220-315-11 is a sterile and preservative-free medication for intravenous infusion only. Each vial contains telavancin hydrochloride, equivalent to 750 mg telavancin for injection, hydroxypropylbetadex, and mannitol. Prior to reconstitution, it should be stored at 2 to 8°C, and after reconstitution, it should be used within 12 hours at room temperature or within 7 days at 2 to 8°C. The medication should be used with caution, and the enclosed medication guide and package insert should be followed for complete directions for use. It is manufactured and dispensed by Cumberland Pharmaceuticals in Nashville, TN.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.